1-2 of 2
Jodi A. Prime
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1 , the criteria for imatinib discontinuation in patients with CML

Clinical Trials & Observations
Susan Branford, David T. Yeung, David M. Ross, Jodi A. Prime, Chani R. Field, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Brad Sullivan, Nancy E. Briggs, Mark Hertzberg, John F. Seymour, John Reynolds, Timothy P. Hughes
Journal: Blood
Blood (2013) 121 (19): 3818–3824.
https://doi.org/10.1182/blood-2012-10-462291
Published: 2013
Journal Articles

BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management

Clinical Trials & Observations
Susan Branford, David T. Yeung, Jodi A. Prime, Soo-Young Choi, Ju-hee Bang, Jin Eok Park, Dong-Wook Kim, David M. Ross, Timothy P. Hughes
Journal: Blood
Blood (2012) 119 (18): 4264–4271.
https://doi.org/10.1182/blood-2011-11-393041
Published: 2012
Includes: Supplemental data